The insulin-like growth factor-I-mTOR signaling pathway induces the mitochondrial pyrimidine nucleotide carrier to promote cell growth

Molecular Biology of the Cell

Volumn 18, Issue 9, 2007, Pages 3545-3555

  Floyd, Suzanne ^a   Favre, Cedric ^a   Lasorsa, Francesco M ^b   Leahy, Madeline ^a   Trigiante, Giuseppe ^a   Stroebel, Philipp ^c   Marx, Alexander ^c   Loughran, Gary ^a   O'Callaghan, Katie ^a   Marobbio, Carlo M T ^b   Slotboom, Dirk J ^d   Kunji, Edmund R S ^d   Palmieri, Ferdinando ^b   O'Connor, Rosemary ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARRIER PROTEIN; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN RIM2P; PYRIMIDINE NUCLEOTIDE CARRIER; PYRIMIDINE NUCLEOTIDE CARRIER PNC1; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN; SOMATOMEDIN C; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL SIZE; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; FUNGUS; HUMAN; HUMAN CELL; HUMAN TISSUE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SIZE; ENZYME ACTIVATION; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MICE; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MOLECULAR SEQUENCE DATA; NUCLEOTIDE TRANSPORT PROTEINS; PROTEIN KINASES; REACTIVE OXYGEN SPECIES; RECEPTOR, IGF TYPE 1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; URIDINE TRIPHOSPHATE;

EID: 34548503176     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E06-12-1109     Document Type: Article

References (46)

1. Altomare, D. A., and Testa, J. R. (2005). Perturbations of the AKT signaling pathway in human cancer. Oncogene 24, 7455-7464.
2. Amuthan, G., Biswas, G., Ananadatheerthavarada, H. K., Vijayasarathy, C., Shephard, H. M., and Avadhani, N. G. (2002). Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene 21, 7839-7849.
3. Biswas, G., Adebanjo, O. A., Freedman, B. D., Anandatheerthavarada, H. K., Vijayasarathy, C., Zaidi, M., Kotlikoff, M., and Avadhani, N. G. (1999). Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J. 18, 522-533.
4. Biswas, G., Guha, M., and Avadhani, N. G. (2005). Mitochondria-to-nucleus stress signaling in mammalian cells: nature of nuclear gene targets, transcription regulation, and induced resistance to apoptosis. Gene 354, 132-139.
5. Boonstra, J., and Post, J. A. (2004). Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337, 1-13.
6. Brand, K. A., and Hermfisse, U. (1997). Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J. 11, 388-395.
7. Butow, R. A., and Avadhani, N. G. (2004). Mitochondrial signaling: the retrograde response. Mol. Cell 14, 1-15.
8. Cully, M., You, H., Levine, A. J., and Mak, T. W. (2006). Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6, 184-192.
9. Dougherty, D. A. (1996). Cation-pi interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science 271, 163-168.
10. Edinger, A. L., and Thompson, C. B. (2002). Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol. Biol. Cell 13, 2276-2288.
11. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498.
12. Fiermonte, G., Palmieri, L., Dolce, V., Lasorsa, F. M., Palmieri, F., Runswick, M. J., and Walker, J. E. (1998). The sequence, bacterial expression, and functional reconstitution of the rat mitochondrial dicarboxylate transporter cloned via distant homologs in yeast and Caenorhabditis elegans. J. Biol. Chem. 273, 24754-24759.
13. Fiermonte, G., Walker, J. E., and Palmieri, F. (1993). Abundant bacterial expression and reconstitution of an intrinsic membrane-transport protein from bovine mitochondria. Biochem. J. 294(Pt 1), 293-299.
14. Heinemeyer, T. et al. (1998). Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26, 362-367.
15. Hofmann, F., and Garcia-Echeverria, C. (2005). Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discov. Today 10, 1041-1047.
16. Kaplan, R. S. (2001). Structure and function of mitochondrial anion transport proteins. J. Membr. Biol. 179, 165-183.
17. Kim, D. H., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument-Bromage, H., Tempst, P., and Sabatini, D. M. (2002). mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175.
18. Kunji, E. R. (2004). The role and structure of mitochondrial carriers. FEBS Lett. 564, 239-244.
19. LeRoith, D., and Roberts, C. T., Jr. (2003). The insulin-like growth factor system and cancer. Cancer Lett. 195, 127-137.
20. Lopez, T., and Hanahan, D. (2002). Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 1, 339-353.
21. Loughran, G., Healy, N. C., Kiely, P. A., Huigsloot, M., Kedersha, N. L., and O'Connor, R. (2005a). Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses anchorage-independent growth. Mol. Biol. Cell 16, 1811-1822.
22. Loughran, G., Huigsloot, M., Kiely, P. A., Smith, L. M., Floyd, S., Ayllon, V., and O'Connor, R. (2005b). Gene expression profiles in cells transformed by overexpression of the IGF-I receptor. Oncogene 24, 6185-6193.
23. Majewski, N., Nogueira, V., Bhaskar, P., Coy, P. E., Skeen, J. E., Gottlob, K., Chandel, N. S., Thompson, C. B., Robey, R. B., and Hay, N. (2004). Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell 16, 819-830.
24. Marobbio, C. M., Di Noia, M. A., and Palmieri, F. (2006). Identification of a mitochondrial transporter for pyrimidine nucleotides in Saccharomyces cerevisiae: bacterial expression, reconstitution and functional characterization. Biochem. J. 393, 441-446.
25. Palmieri, F. (1994). Mitochondrial carrier proteins. FEBS Lett. 346, 48-54.
26. Palmieri, F. (2004). The mitochondrial transporter family (SLC25): physiological and pathological implications. Pfluegers Arch. 447, 689-709.
27. Palmieri, F., Indiveri, C., Bisaccia, F., and Iacobazzi, V. (1995). Mitochondrial metabolite carrier proteins: purification, reconstitution, and transport studies. Methods Enzymol. 260, 349-369.
28. Palmieri, L., Runswick, M. J., Fiermonte, G., Walker, J. E., and Palmieri, F. (2000). Yeast mitochondrial carriers: bacterial expression, biochemical identification and metabolic significance. J. Bioenerg. Biomembr. 32, 67-77.
29. Pebay-Peyroula, E., Dahout-Gonzalez, C., Kahn, R., Trezeguet, V., Lauquin, G. J., and Brandolin, G. (2003). Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature 426, 39-44.
30. Plas, D. R., Talapatra, S., Edinger, A. L., Rathmell, J. C., and Thompson, C. B. (2001). Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology. J. Biol. Chem. 276, 12041-12048.
31. Plas, D. R., and Thompson, C. B. (2005). Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24, 7435-7442.
32. Rancourt, R. C., Hayes, D. D., Chess, P. R., Keng, P. C., and O'Reilly, M. A. (2002). Growth arrest in G1 protects against oxygen-induced DNA damage and cell death. J. Cell. Physiol. 193, 26-36.
33. Samuels, Y., and Ericson, K. (2006). Oncogenic PI3K and its role in cancer. Curr. Opin. Oncol. 18, 77-82.
34. Sarbassov, D. D., and Sabatini, D. M. (2005). Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex. J. Biol. Chem. 280, 39505-39509.
35. Scarpulla, R. C. (2002). Transcriptional activators and coactivators in the nuclear control of mitochondrial function in mammalian cells. Gene 286, 81-89.
36. Schieke, S. M., and Finkel, T. (2006). Mitochondrial signaling, TOR, and life span. Biol. Chem. 387, 1357-1361.
37. Schieke, S. M., Phillips, D., McCoy, J. P., Jr., Aponte, A. M., Shen, R. F., Balaban, R. S., and Finkel, T. (2006). The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem. 281, 27643-27652.
38. Schmelzle, T., and Hall, M. N. (2000). TOR, a central controller of cell growth. Cell 103, 253-262.
39. Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., and Baserga, R. (1994). Effect of a null mutation of the insulin-like growth factor 1 receptor gene on growth and transformation of mouse embryo fibroblasts. Mol. Cell. Biol. 14, 3604-3612.
40. Skeen, J. E., Bhaskar, P. T., Chen, C. C., Chen, W. S., Peng, X. D., Nogueira, V., Hahn-Windgassen, A., Kiyokawa, H., and Hay, N. (2006). Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell 10, 269-280.
41. Titus, S. A., and Moran, R. G. (2000). Retrovirally mediated complementation of the glyB phenotype. Cloning of a human gene encoding the carrier for entry of folates into mitochondria. J. Biol. Chem. 275, 36813-36817.
42. Todisco, S., Agrimi, G., Castegna, A., and Palmieri, F. (2006). Identification of the mitochondrial NAD+ transporter in Saccharomyces cerevisiae. J. Biol. Chem. 281, 1524-1531.
43. Van Dyck, E., Jank, B., Ragnini, A., Schweyen, R. J., Duyckaerts, C., Sluse, F., and Foury, F. (1995). Overexpression of a novel member of the mitochondrial carrier family rescues defects in both DNA and RNA metabolism in yeast mitochondria. Mol. Gen. Genet 246, 426-436.
44. Wang, B., Li, N., Sui, L., Wu, Y., Wang, X., Wang, Q., Xia, D., Wan, T., and Cao, X. (2004). HuBMSC-MCP, a novel member of mitochondrial carrier superfamily, enhances dendritic cell endocytosis. Biochem. Biophys. Res. Commun. 314, 292-300.
45. Warburg, O. (1924). Uber den Stoffwechsel der Carcinomzelle. Biochem. Z. 152, 309-344.
46. Warburg, O., Posener, K., and Negelein, E. (1930). The Metabolism of Tumours, London: Arnold Constable.